Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses

Vaccine

Volumn 19, Issue 20-22, 2001, Pages 2955-2964

  Seong, Young Rim ^a   Choi, Seeyoung ^a   Lim, Jong Seok ^a   Lee, Chan Hee ^b   Lee, Chong Kyo ^c   Im, Dong Soo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungbuk National University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Hepatitis C virus envelope proteins E1 and E2; Immunogenicity; Recombinant adenovirus

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CANCER CELL; CELL DIVISION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD; FEMALE; HELA CELLS; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HUMANS; IMMUNIZATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL ENVELOPE PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0035815490     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00534-X     Document Type: Article

References (43)

1. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
2. Isolation of a cDNA cloned derived from a blood-borne non-A, non-B viral hepatitis genome
3. An assay for circulating antibodies to a major etiologic virus of non-A, non-B hepatitis
4. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
5. Vaccinia virus: A tool for research and vaccine development
6. Genetic organization and diversity of the hepatitis C virus
7. Molecular biology of hepatitis C virus
8. Biosynthesis and biochemical properties of the hepatitis C virus core protein
9. Formation of native hepatitis C virus glycoprotein complexes
10. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
11. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
12. Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant
13. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
14. Vaccination of chimpanzees against infection by the hepatitis C virus
15. Binding of hepatitis C virus to CD81
16. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein
17. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein
18. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface
19. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV
20. A proposed system for the nomenclature of hepatitis C viral genotypes
21. Cytotoxic T lymphocytes
22. Cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis
23. Direct gene transfer into mouse muscle in vivo
24. Novel vaccine approaches
25. Adenovirus-based expression vectors and recombinant vaccines
26. Recombinant adenoviruses as vaccines
27. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector
28. Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus
29. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus
30. A recombinant human adenovirus vaccine against rabies
31. Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: Effects on adenovirus gene expression and replication
32. Methods for construction of adenovirus vectors
33. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
34. Overexpression and simple purification of a truncated, immunologically reactive GST-HCV core (1-123) fusion protein
35. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
36. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene
37. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization
38. Structure-function analysis of hepatitis C virus envelope-CD81 binding
39. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: An endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates
40. A qauntitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
41. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
42. Cellular immune response to the hepatitis C virus
43. Quantitative analysis of peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection